REMS And Benefits? FDA, Industry Debate Moving Beyond Safety Information

Included in FDA's upcoming look at improving Risk Evaluation and Mitigation Strategies may be an adjustment to Medication Guides to include drug benefits alongside risks

More from Archive

More from Pink Sheet